Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
CD19 CAR T-cell
Universal Integrated
B-cell Acute Lymphoblastic Leukemia
1 trial -
CHO+PRO
United Therapeutics Europe Ltd
High Altitude
1 trial -
CLP: Nutrition
United Therapeutics Europe Ltd
Child Nutritional Status
1 trial -
CMGV
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Recurrent Adult Acute Myeloid Leukemia
1 trial -
CMV-VST
Chongqing Precision Biotech Co., Ltd
Cytomegalovirus Viremia
1 trial -
CSB drum dried + Ξ±-amylase
United Therapeutics Europe Ltd
Malnutrition
1 trial -
CSB14
United Therapeutics Europe Ltd
Child Malnutrition
1 trial -
CT scan
United Therapeutics Europe Ltd
Hospital-acquired Pneumonia
1 trial -
CT-FFR assessment
The First People's Hospital of Lianyungang
Coronary Artery Disease
1 trial -
CTCA
United Therapeutics Europe Ltd
Coronary Heart Disease
1 trial -
CYP2C19 genotype testing
Beijing Anzhen Hospital
Angina, Stable
1 trial -
Ca/Vit D
United Therapeutics Europe Ltd
Bone Health
1 trial -
Caffeine
United Therapeutics Europe Ltd
Post Dural Puncture Headache
1 trial -
Calcium & Vitamin D
United Therapeutics Europe Ltd
Stress Fracture
1 trial -
Calcium Carbonate 1500 Mg with Vitamin D
Hospital Authority, Hong Kong
Thyroid Neoplasm
1 trial -
Calcium/Vitamin D
United Therapeutics Europe Ltd
Nutrition Status
1 trial -
Cambridge Weight Plan
United Therapeutics Europe Ltd
Diabetes
1 trial -
Camel Milk
United Therapeutics Europe Ltd
Healthy
1 trial -
Canagliflozin
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus With Complication
1 trial -
Cannabis (30% THC Concentrate)
BRIGHT MINDS BIOSCIENCES INC.
THC
1 trial -
Capsule 1 or Capsule 2
United Therapeutics Europe Ltd
Pregnancy
1 trial -
Carbon ion radiotherapy
Shanghai Proton and Heavy Ion Center
Pancreatic Cancer Non-resectable
1 trial -
Cardiac MRI with gadolinium contrast
United Therapeutics Europe Ltd
Heart Failure
1 trial -
Cardiopulmonary Exercise Testing
Esperion Therapeutics
Intrauterine Growth Restriction
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources